Advanced search
Publication Cover
Psoriasis: Targets and Therapy Volume 11, 2021 - Issue
Submit an article Journal homepage
144
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness of IL-23 Inhibitor Guselkumab in Real-World Chinese Patients with Psoriasis During a 20-Week Period

Yung ChanApex Dermatology Institute, Kowloon, Hong KongCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3330-329XView further author information
ORCID Icon,
Bik Sai Bessie TongApex Dermatology Institute, Kowloon, Hong KongView further author information
,
Pui Yan NganApex Dermatology Institute, Kowloon, Hong KongView further author information
&
Chi Sum AuApex Dermatology Institute, Kowloon, Hong KongView further author information
Pages 53-58 | Published online: 01 Jun 2021

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Marco Galluzzo, Marina Talamonti, Nicoletta Bernardini, Andrea Chiricozzi, Clara De Simone, Claudio Bonifati, Pierluigi Bruni, Federico Diotallevi, Maria Esposito, Dario Graceffa, Katharina Hansel, Francesco Loconsole, Gaia Moretta, Cristina Mugheddu, Manuela Papini, Antonio Richetta, Nevena Skroza, Laura Atzori, Maria Concetta Fargnoli, Severino Persechino, Annamaria Offidani, Luca Stingeni, Ketty Peris, Concetta Potenza & Luca Bianchi. (2022) Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year. Expert Opinion on Biological Therapy 22:12, pages 1585-1592.
Read now

Articles from other publishers (1)

. (2021) Guselkumab. Reactions Weekly 1875:1, pages 156-156.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.